Evidence-based pharmacotherapy for personality disorders.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Personality disorders are frequently treated with psychotropic medications, often without robust data.
• Current prescribing relies on anecdotal evidence, highlighting a need for evidence-based strategies.
• Neurobiological understanding is advancing the conceptualization of personality disorders and psychopharmacological targets.

Purpose of the Study:

• To review existing evidence on medication treatment for personality disorders.
• To outline optimal strategies for evidence-based pharmacotherapy in these patients.
• To identify areas for future research in rational pharmacotherapy development.

Main Methods:

• Systematic review of available evidence on psychotropic medication for personality disorders.
• Focus on borderline, schizotypal, avoidant, and antisocial personality disorders.
• Analysis of medication efficacy in specific symptom domains and associated risks.

Main Results:

• Pharmacotherapy shows efficacy in reducing impulsivity and aggression in borderline and antisocial personality disorders.
• Antidepressants, antipsychotics, and mood stabilizers can alleviate maladaptive personality symptoms partially.
• Medications show promise for psychotic-like symptoms in schizotypal personality disorder and social anxiety in avoidant personality disorder.

Conclusions:

• Evidence-based pharmacotherapy provides partial improvement for specific symptom domains in personality disorders.
• Careful risk-benefit assessment is crucial for effective medication management.
• Further research into neurobiological underpinnings is essential for developing targeted and rational pharmacotherapies.